Patent Assignment
Reel/Frame 035854/0162
SECURITY INTEREST
Recorded: 2015-06-15
Received: 2015-06-17
Pages: 25
Assignor
RIDGE DIAGNOSTICS, INC.
Executed: 2015-06-15
Assignee
VINDRAUGA CORPORATION
1565 HOTEL CIRCLE SOUTH, SUITE 310, SAN DIEGO, CA, 92108, UNITED STATES
Covered Applications
(35)
BROADBAND DISTRIBUTED ANTENNA SYSTEM WITH NON-DUPLEXER ISOLATOR SUB-SYSTEM
App. No. 14/742,129
→
DYNAMIC WEBPAGE INTERFACE FOR AN INTELLIGENT ELECTRONIC DEVICE
App. No. 14/742,302
→
METHODS AND MATERIALS FOR TREATING PAIN AND DEPRESSION
App. No. 62/020,033
→
MULTIPLE BIOMARKER PANELS TO STRATIFY DISEASE SEVERITY AND MONITOR TREATMENT OF DEPRESSION
App. No. 14/299,303
→
HUMAN BIOMARKER TEST FOR MAJOR DEPRESSIVE DISORDER
App. No. 14/211,560
→
DIAGNOSING AND MONITORING DEPRESSION DISORDERS
App. No. 14/154,989
→
QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
App. No. 13/903,346
→
Metabolic Syndrome and HPA Axis Biomarkers for Major Depressive Disorder
App. No. 13/892,714
→
HUMAN BIOMARKER TEST FOR MAJOR DEPRESSIVE DISORDER
App. No. 61/798,910
→
QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
App. No. 13/446,382
→
BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
App. No. 13/312,553
→
INFLAMMATORY BIOMARKERS FOR MONITORING DEPRESSIVE DISORDERS
App. No. 12/922,365
→
DIAGNOSING AND MONITORING DEPRESSION DISORDERS BASED ON MULTIPLE SERUM BIOMARKER PANELS
App. No. 12/921,349
→
Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
App. No. 13/014,413
→
BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
App. No. 61/420,141
→
METHODS FOR TREATING NEUROPSYCHIATRIC DISESE
App. No. 12/754,770
→
BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
App. No. 12/753,022
→
Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
App. No. 61/298,443
→
METABOLIC SYNDROME AND HPA AXIS BIOMARKERS FOR MAJOR DEPRESSIVE DISORDER
App. No. 12/620,831
→
HUMAN BIOMARKER HYPERMAPPING FOR DEPRESSIVE DISORDERS
App. No. 12/579,733
→
Optical Molecular Detection
App. No. 12/305,950
→
BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
App. No. 61/166,986
→
BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES
App. No. 61/165,662
→
Combinations of Metabolic Syndrome and HPA Axis Biomarkers for Monitoring Major Depressive Disorder
App. No. 61/115,710
→
HUMAN BIOMARKER HYPERMAPPING FOR DEPRESSIVE DISORDERS
App. No. 61/105,641
→
Inflammatory Biomarkers for Monitoring Depressive Disorders
App. No. 61/036,013
→
Monitoring Depression Disorders Based on Hypothalamic-Pituitary-Adrenal (HPA) Axis Biomarkers
App. No. 61/033,731
→
Combinations of Selected Biomarkers for Diagnosing Depression Disorders
App. No. 61/033,721
→
Monitoring Depression Disorders Based on Multiple Serum Biomarker Panels
App. No. 61/033,726
→
QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
App. No. 11/850,550
→
Quantative methods using multiple parameters in diagnostics
App. No. 60/910,217
→
Quantative methods using multiple parameters in diagnostics
App. No. 60/824,471
→
Precision molecule interaction measurement system and method
App. No. 60/796,585
→
Molecular interaction detection chip and fabrication process
App. No. 60/784,322
→
Molecule interaction measurement chip and system
App. No. 60/748,824
→